.RESEARCH STUDY HIGHLIGHT.16 October 2024.
In the NIAGARA hearing, the addition of perioperative durvalumab to typical procedure for muscle-invasive bladder cancer cells enhanced event-free and on the whole survival, noting a brand new treatment choice for this health condition.